Labcorp Holdings (LH) is a Top-Ranked Value Stock: Should You Buy?

Company Overview - Labcorp Holdings, headquartered in Burlington, NC, is a leading healthcare diagnostics company that provides comprehensive clinical laboratory services and end-to-end drug development support [11] - In 2015, Labcorp acquired Covance, a drug development services company that offers a wide range of early-stage and late-stage product development services primarily to the pharmaceutical and biotechnology industries [11] Investment Ratings - Labcorp is currently rated as 3 (Hold) on the Zacks Rank, with a VGM Score of A, indicating a strong overall performance [12] - The company has a Value Style Score of B, supported by attractive valuation metrics such as a forward P/E ratio of 15.64, which may appeal to value investors [12] Earnings Estimates - In the last 60 days, four analysts have revised their earnings estimates higher for fiscal 2026, with the Zacks Consensus Estimate increasing by $0.04 to $17.65 per share [12] - Labcorp has an average earnings surprise of +3.1%, suggesting a positive trend in earnings performance [12] Investment Consideration - With a solid Zacks Rank and top-tier Value and VGM Style Scores, Labcorp should be considered for investors' short lists [13]